Michael Kaling

770 total citations
17 papers, 645 citations indexed

About

Michael Kaling is a scholar working on Molecular Biology, Genetics and Biochemistry. According to data from OpenAlex, Michael Kaling has authored 17 papers receiving a total of 645 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Molecular Biology, 9 papers in Genetics and 3 papers in Biochemistry. Recurrent topics in Michael Kaling's work include Estrogen and related hormone effects (4 papers), Lipid metabolism and biosynthesis (3 papers) and Animal Genetics and Reproduction (3 papers). Michael Kaling is often cited by papers focused on Estrogen and related hormone effects (4 papers), Lipid metabolism and biosynthesis (3 papers) and Animal Genetics and Reproduction (3 papers). Michael Kaling collaborates with scholars based in Germany, United States and Russia. Michael Kaling's co-authors include Gerhart U. Ryffel, Detlev Ganten, John J. Mullins, Wilfried Kugler, Rainer Metzger, Ulrike Wagner, Kjell Fuxé, Ulrich Hilgenfeldt, Shoji Kimura and H. Jacob and has published in prestigious journals such as Nucleic Acids Research, The EMBO Journal and Journal of Molecular Biology.

In The Last Decade

Michael Kaling

16 papers receiving 624 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Michael Kaling Germany	10	286	274	261	214	65	17	645
Victoria South United States	5	263 0.9×	220 0.8×	290 1.1×	56 0.3×	43 0.7×	8	655
Yoshiko Nakagomi Japan	11	312 1.1×	151 0.6×	124 0.5×	91 0.4×	24 0.4×	22	520
Dolkun Rahmutula Japan	15	179 0.6×	392 1.4×	128 0.5×	72 0.3×	39 0.6×	22	699
Fiona O’Mahony Ireland	14	303 1.1×	117 0.4×	143 0.5×	291 1.4×	25 0.4×	17	728
Monica Florio Italy	11	370 1.3×	107 0.4×	170 0.7×	50 0.2×	38 0.6×	13	563
W E Rainey United States	13	207 0.7×	79 0.3×	278 1.1×	131 0.6×	15 0.2×	17	486
Roberta Minotti Switzerland	7	272 1.0×	69 0.3×	306 1.2×	395 1.8×	58 0.9×	8	777
Mathias Hampf Germany	7	258 0.9×	86 0.3×	224 0.9×	99 0.5×	20 0.3×	9	525
Caroline A. Wallace United Kingdom	5	376 1.3×	94 0.3×	117 0.4×	171 0.8×	19 0.3×	6	652
Shozo Torikai Japan	13	327 1.1×	108 0.4×	132 0.5×	74 0.3×	36 0.6×	25	729

Countries citing papers authored by Michael Kaling

Since Specialization

Citations

This map shows the geographic impact of Michael Kaling's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Michael Kaling with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Michael Kaling more than expected).

Fields of papers citing papers by Michael Kaling

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Michael Kaling. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Michael Kaling. The network helps show where Michael Kaling may publish in the future.

Co-authorship network of co-authors of Michael Kaling

This figure shows the co-authorship network connecting the top 25 collaborators of Michael Kaling. A scholar is included among the top collaborators of Michael Kaling based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Michael Kaling. Michael Kaling is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

17 of 17 papers shown

1.

Kreutz, Reinhold, Shokei Kim, Martina Schinke, et al.. (1995). Angiotensin II receptor blockade in TGR(mREN2)27: effects of renin???angiotensin-system gene expression and cardiovascular functions. Journal of Hypertension. 13(8). 891–899. 89 indexed citations

2.

Bäder, Michael, et al.. (1992). Basic methodology in the molecular characterization of genes. Journal of Hypertension. 10(1). 9–16. 5 indexed citations

3.

Klett, C. James, et al.. (1992). Regulation of hepatic angiotensinogen synthesis and secretion by steroid hormones.. Endocrinology. 130(6). 3660–3668. 68 indexed citations

4.

Morano, Ingo, et al.. (1992). Regulation of myosin heavy chain (MHC) gene expression in cardiac hypertrophy: Effects of testosterone and cAMP. Journal of Molecular and Cellular Cardiology. 24. S26–S26. 1 indexed citations

5.

Kimura, Shoji, John J. Mullins, Bernd Bunnemann, et al.. (1992). High blood pressure in transgenic mice carrying the rat angiotensinogen gene.. The EMBO Journal. 11(3). 821–827. 169 indexed citations

6.

Niedermaier, N., H. Drexler, Michael Kaling, & Detlev Ganten. (1991). 110. Left ventricular hypertrophy and myocardial infarction increase left ventricular angiotensinogen gene expression. Journal of Hypertension. 9. S470–S470. 1 indexed citations

7.

Kaling, Michael, et al.. (1991). Liver-Specific Gene Expression: A-Activator-Binding Site, a Promoter Module Present in Vitellogenin and Acute-Phase Genes. Molecular and Cellular Biology. 11(1). 93–101. 5 indexed citations

8.

Kaling, Michael, et al.. (1991). Glucocorticoid- and estrogen-responsive elements in the 5???-flanking region of the rat angiotensinogen gene. Journal of Hypertension. 9(11). 1005–1012. 50 indexed citations

9.

Kaling, Michael, Wilfried Kugler, Kenneth N. Ross, Christiane Zoidl, & Gerhart U. Ryffel. (1991). Liver-specific gene expression: A-activator-binding site, a promoter module present in vitellogenin and acute-phase genes.. Molecular and Cellular Biology. 11(1). 93–101. 25 indexed citations

10.

Kaling, Michael, et al.. (1991). 81. Requirements for expression of the angiotensin gene in tissue cell and transgenic animals. Journal of Hypertension. 9(6). S456–S456. 1 indexed citations

11.

Niedermaier, N., H. Drexler, Michael Kaling, & Detlev Ganten. (1991). 110. Left ventricular hypertrophy and myocardial infarction increase left ventricular angiotensinogen gene expression. Journal of Hypertension. 9(6). S470–S470. 3 indexed citations

12.

Kaling, Michael, et al.. (1990). Transcription factors different from the estrogen receptor stimulate in vitro transcription from promoters containing estrogen response elements. Molecular and Cellular Endocrinology. 69(2-3). 167–178. 15 indexed citations

13.

Kugler, Wilfried, Michael Kaling, Ulrike Wagner, & Gerhart U. Ryffel. (1990). BAP, a rat liver protein that activates transcription through a promoter element with similarity to the USF/MLTF binding site. Nucleic Acids Research. 18(23). 6943–6951. 16 indexed citations

14.

Ryffel, Gerhart U., Wilfried Kugler, Ulrike Wagner, & Michael Kaling. (1989). Liver cell specific gene transcriptionin vitro: the promoter elements HP1 and TATA box are necessary and sufficient to generate a liver-specific promoter. Nucleic Acids Research. 17(3). 939–953. 57 indexed citations

15.

Kaling, Michael, et al.. (1988). Synergism of closely adjacent estrogen-responsive elements increases their regulatory potential. Journal of Molecular Biology. 201(3). 537–544. 100 indexed citations

16.

Löffelhardt, Wolfgang, Hermann AM Mucke, Heimo Breiteneder, et al.. (1987). The Cyanelle Genome of Cyanophora paradoxa. Annals of the New York Academy of Sciences. 503(1). 550–552. 6 indexed citations

17.

Steinm�ller, Klaus, Michael Kaling, & Klaus Zetsche. (1983). In-vitro synthesis of phycobiliproteids and ribulose-1,5-bisphosphate carboxylase by non-poly-adenylated-RNA of Cyanidium caldarium and Porphyridium aerugineum. Planta. 159(4). 308–313. 34 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact